|
Demarest, J F; Jack, N; Cleghorn, F R et al. (2001) Immunologic and virologic analyses of an acutely HIV type 1-infected patient with extremely rapid disease progression. AIDS Res Hum Retroviruses 17:1333-44
|
|
Tyler, D S; Stanley, S D; Bartlett, J A et al. (1998) Lymphokine-activated killer (LAK) cell anti-HIV-1 ADCC reactivity: a potential strategy for reduction of virus-infected cellular reservoirs. J Surg Res 79:115-20
|
|
Ferrari, G; Humphrey, W; McElrath, M J et al. (1997) Clade B-based HIV-1 vaccines elicit cross-clade cytotoxic T lymphocyte reactivities in uninfected volunteers. Proc Natl Acad Sci U S A 94:1396-401
|
|
Greenberg, M L; Lacey, S F; Chen, C H et al. (1997) Noncytolytic CD8 T cell-mediated suppression of HIV replication. Springer Semin Immunopathol 18:355-69
|
|
Ferrari, G; Berend, C; Ottinger, J et al. (1997) Replication-defective canarypox (ALVAC) vectors effectively activate anti-human immunodeficiency virus-1 cytotoxic T lymphocytes present in infected patients: implications for antigen-specific immunotherapy. Blood 90:2406-16
|
|
Ferrari, G; King, K; Rathbun, K et al. (1995) IL-7 enhancement of antigen-driven activation/expansion of HIV-1-specific cytotoxic T lymphocyte precursors (CTLp). Clin Exp Immunol 101:239-48
|
|
Ahearne, P M; Morgan, R A; Sebastian, M W et al. (1995) Multiple CTL specificities against autologous HIV-1-infected BLCLs. Cell Immunol 161:34-41
|
|
Toso, J F; Chen, C H; Mohr, J R et al. (1995) Oligoclonal CD8 lymphocytes from persons with asymptomatic human immunodeficiency virus (HIV) type 1 infection inhibit HIV-1 replication. J Infect Dis 172:964-73
|
|
Ferrari, G; Place, C A; Ahearne, P M et al. (1994) Comparison of anti-HIV-1 ADCC reactivities in infected humans and chimpanzees. J Acquir Immune Defic Syndr 7:325-31
|
|
Ferrari, G; Ottinger, J; Place, C et al. (1993) The impact of HIV-1 infection on phenotypic and functional parameters of cellular immunity in chimpanzees. AIDS Res Hum Retroviruses 9:647-56
|
Showing the most recent 10 out of 12 publications
